Pharma
The AIPPI Pharma Committee monitors, comments and advises AIPPI on policy, regulatory and legal frameworks relating to intellectual property protection for pharmaceutical products and processes, diagnostic products and medical devices. The Committee also considers policy initiatives, and best practices for national and regional legislation.
Standing Committee
Pharma
Status: Active
Committee Leadership
Charles Aaron BOULAKIA (CA) (Vice Chair)
Martin KLOK (NL) (Vice Chair)

John C. TODARO (US ) (Chair)
Committee Members
Hameeda ASIF (PK)
Ezgi BAKLACI GÜLKOKAR (TR)
Martín BENSADON (AR)
Cristina BIGGI (IT)
Anna BLADH REDZIC (SE)

Mariangela BOGNI (IT)
Brigitte CARION TARAVELLA (FR)
Héctor E. CHAGOYA C. (MX)
I. Soley COBAN (TR)
Magali CONTARDI (IT)
Magnus DAHLMAN (SE)

Li FENG (US)
Kevin CW FENG (TW)
Amy FENG (CN)